Sort By

  • Newest

  • Newest

  • Oldest

  • Author Name

  • Author Name

  • David Chaplin

  • Drew Meredith

  • Giselle Roux

  • Greg Bright

  • Ishan Dan

  • James Dunn

  • Lachlan Maddock

  • Owen Raszkiewicz

ClearView’s strategic evolution to a life insurer coming to fruition

An ASX “please explain” letter after the stock was heavily sold threw a spanner in the works late last year, but since then ClearView’s transformation is back on track with a solid 2025 result expected. For the life insurance play’s shareholders, there’s the bonus of a share buyback in the wings.
Jamie Nemtsas | 4th Jun 2025 | More